The store will not work correctly when cookies are disabled.
5-Pyridin-3-yl-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA80505
PubChem CID: 10444655
Max Phase: Preclinical
Molecular Formula: C16H13N3
Molecular Weight: 247.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C1=C(c2cccnc2)N2CCN=C2c2ccccc21
Standard InChI: InChI=1S/C16H13N3/c1-2-6-14-12(4-1)10-15(13-5-3-7-17-11-13)19-9-8-18-16(14)19/h1-7,10-11H,8-9H2
Standard InChI Key: AOUCELMJZHXMIS-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
2.4000 -5.4792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8875 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4292 -4.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9167 -4.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3667 -5.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8875 -6.3875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3875 -4.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9667 -4.6250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0042 -4.6792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9167 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9167 -6.3875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4667 -4.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8375 -5.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8750 -4.5417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9917 -4.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0292 -4.0792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5167 -3.7542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3250 -5.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3417 -4.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 12 1 0
10 1 1 0
11 10 1 0
12 8 2 0
13 5 1 0
14 7 1 0
15 8 1 0
16 17 1 0
17 15 2 0
18 13 2 0
19 14 2 0
11 6 1 0
7 5 2 0
16 9 2 0
18 19 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 247.30 | Molecular Weight (Monoisotopic): 247.1109 | AlogP: 2.66 | #Rotatable Bonds: 1 |
Polar Surface Area: 28.49 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.90 | CX LogP: 1.84 | CX LogD: 1.72 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.77 | Np Likeness Score: -0.46 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |